Page last updated: 2024-11-05

tolazoline and Atrophy

tolazoline has been researched along with Atrophy in 1 studies

Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schreyer, H1
Schwarz, G1
Kerl, H1

Other Studies

1 other study available for tolazoline and Atrophy

ArticleYear
[Pharmaco-angiography with Priscolin in progressive scleroderma (author's transl)].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1976, Volume: 125, Issue:3

    Topics: Adolescent; Adult; Aged; Arteries; Atrophy; Collateral Circulation; Edema; Female; Fingers; Hand; Hu

1976